Clinical Trial Update: Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ENV-294 in healthy adults and adults with moderate-to-severe atopic dermatitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• ENV-294

Snippet

Sponsor: Enveda Therapeutics | Conditions: Atopic Dermatitis (AD) | Phase 1 | Status: COMPLETED